Alprazolam is a triazolobenzodiazepine, with a potent anxiolytic actio
n and a short half-life. Alprazolam analgesia was measured, using the
radiant heat tailfIick assay in mice, which was administered alone or
in combination with opioids. Intrathecally administered alprazolam pro
duced a dose-response increase in the tailfIick latency with an ED(50)
of 34 mu g (19.4-72.5, 95% CL). There were almost no effects after in
tracerebroventricular injections. Naloxone almost completely abolished
the analgesia response mediated by alprazolam. This sensitivity to na
loxone indicates that at least some of the analgesic effects of alpraz
olam are mediated by an opioid mechanism of action. When administered
together with various antagonists of opioid receptor subtypes, we foun
d that the mu antagonists, but not the delta and kappa(1) subtypes inh
ibited alprazolam analgesia significantly. Mo effect was found when al
prazolam was coadministrated with kappa(3) opioid agonists. In additio
n, we found a supra-additivity (synergistic) increase in analgesia whe
n alprazolam was given with morphine. Competition binding assays show
the highest affinity of alprazolam to the mu(1) subtype. In summary, w
e conclude that alprazolam mediates its analgesic effect, most probabl
y via an mu opiate mechanism of action. Copyright (C) 1997 Elsevier Sc
ience Inc.